In this report, the global Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosimilars in these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
For further inquiries, about – Global Biosimilars Industry Analysis, Size, Growth, Trends and Forecast to 2022, click on this link – https://www.radiantinsights.com/research/global-biosimilars-industry-2017
Global Biosimilars market competition by top manufacturers, with production, price, and revenue (value) and market share for each manufacturer; the top players including
• Pfizer
• Sandoz International GmbH
• Teva Pharmaceuticals Industries
• Amgen Inc
• Biocon
• Dr. Reddy’s Laboratories
• F. Hoffmann-La Roche
• Celltrion
• Samsung Bioepis
Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-biosimilars-industry-2017/request-sample
On the basis of product, this report displays the production, revenue, price, and market share and growth rate of each type, primarily split into
• Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
• Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
• Peptides (Glucagon, Calcitonin)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Oncology
• Blood Disorders
Read more related reports by Radiant Insights:
• Multiple Sclerosis (MS) Drugs Industry
• Actinic Keratosis Drugs Industry
https://www.radiantinsights.com/research/global-and-chinese-actinic-keratosis-drugs-industry-2017
Table of Contents
1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type (Product Category)
1.2.1 Global Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Biosimilars Production Market Share by Type (Product Category) in 2016
1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.5 Peptides (Glucagon, Calcitonin)
1.3 Global Biosimilars Segment by Application
1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Global Biosimilars Market by Region (2012-2022)
1.4.1 Global Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Biosimilars (2012-2022)
1.5.1 Global Biosimilars Revenue Status and Outlook (2012-2022)
1.5.2 Global Biosimilars Capacity, Production Status and Outlook (2012-2022)
To read more reports of this category, Visit our blog: https://pharmaceuticalandhealthcarereports.weebly.com
About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.radiantinsights.com/research/global-biosimilars-industry-2017